“Based on artificial intelligence and natural language processing, ‘LOLA’, is able to make more than 40 phone calls in two hours, allowing us to gather follow-up information and act accordingly. Results from the TeleTAVI study indicate that we can provide excellent care virtually, without substantially increasing resources.”
.png)
Madrid, 30th August, 2024 - Doctor Marta Herrero Brocal will be presenting at the European Society of Cardiology Congress the outstanding results of implementing Tucuvi’s AI in the Post-TAVI Pathway.
“The TeleTAVI study found that follow-up with a virtual voice assistant enabled safe and early discharge after TAVI, with a low complication rate and without increasing the burden on healthcare resources.”
Time efficiency: 1,039 calls made, 385 hours of autonomous conversation, with 94% patient engagement.
Faster patient discharge: Knowing that automated close follow-up was available, 40.1% of patients were able to be discharged within 24 hours of the procedure and 32.9% between 24 and 48 hours.
Great patient satisfaction: 86% of patients said that they would recommend the use of LOLA.
For more details about the results, check out the full article here
Tucuvi:
Clinically Validated
AI for Healthcare
Book a demo